ALNY logo

Alnylam Pharmaceuticals, Inc. (ALNY) EV/EBITDA

EV/EBITDA:

-395.51+11.49(+2.82%)
August 22, 2025

Summary

  • As of today (August 25, 2025), ALNY EV/EBITDA is -395.51, with a rise of +11.49 (+2.82%) during the most recent trading session on August 22, 2025.
  • Over the past year, ALNY EV/EBITDA has dropped by -690.22 (-234.20%).
  • ALNY EV/EBITDA is now -229.69% below its all-time high of 304.97.

Performance

ALNY EV/EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

OtherALNYvaluation metrics

EV/EBITDA Formula

EV/EBITDA =  
Enterprise Value
TTM EBITDA

ALNY EV/EBITDA Trends

PeriodPeriodEV/EBITDAEV/EBITDAEnterprise valueEnterprise valuePricePrice
todaytoday+2.8%-2.8%-2.8%
1 m1 month-39.9%+39.9%+39.7%
3 m3 months-38.3%+57.4%+57.2%
6 m6 months-92.7%+83.0%+81.3%
ytdytd-105.5%+95.1%+93.1%
1 y1 year-234.2%+66.6%+63.8%
5 y5 years-1858.9%+289.9%+232.6%

ALNY EV/EBITDA Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month-282.49-40.0%-407.00+2.8%
3 m3-month-270.35-46.3%-407.00+2.8%
6 m6-month-191.84-106.2%-407.00+2.8%
1 y1-year304.97-229.7%-407.00+2.8%
3 y3-year304.97-229.7%-407.00+2.8%
5 y5-year304.97-229.7%-407.00+2.8%
alltimeall time304.97-229.7%-407.00+2.8%

ALNY EV/EBITDA History

DateValue
2025
-395.51(+105.5%)
2024
-192.50(+89.4%)
2023
-101.66(+209.8%)
2022
-32.81(+1.0%)
2021
-32.50(+52.5%)
2020
-21.31(+52.9%)
2019
-13.94(+64.4%)
DateValue
2018
-8.48(-62.4%)
2017
-22.54(+236.9%)
2016
-6.69(-73.3%)
2015
-25.02(-36.5%)
2014
-39.42(-15.4%)
2013
-46.58(+204.2%)
2012
-15.31

FAQ

  • What is Alnylam Pharmaceuticals, Inc. EV/EBITDA?
  • What is the all time high EV/EBITDA for Alnylam Pharmaceuticals, Inc.?
  • What is ALNY EV/EBITDA year-to-date change?
  • What is Alnylam Pharmaceuticals, Inc. EV/EBITDA year-on-year change?

What is Alnylam Pharmaceuticals, Inc. EV/EBITDA?

The current EV/EBITDA of ALNY is -395.51

What is the all time high EV/EBITDA for Alnylam Pharmaceuticals, Inc.?

Alnylam Pharmaceuticals, Inc. all-time high EV/EBITDA is 304.97

What is ALNY EV/EBITDA year-to-date change?

Alnylam Pharmaceuticals, Inc. EV/EBITDA has changed by -203.01 (-105.46%) since the beginning of the year

What is Alnylam Pharmaceuticals, Inc. EV/EBITDA year-on-year change?

Over the past year, ALNY EV/EBITDA has changed by -690.22 (-234.20%)
On this page